May 16, 2023 02:02 PM EDT
Pharma
FDA+

FDA sig­nals sup­port for Pfiz­er’s RSV shot in ad­comm docs be­fore cru­cial vote

Andrew Dunn

Senior Biopharma Correspondent

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Lil­ly shuf­fles key ex­ec­u­tive po­si­tions; Mikael Dol­sten takes an­oth­er post-Pfiz­er as­sign­ment

Corvus' ear­ly-phase atopic der­mati­tis da­ta prompt stock ral­ly

Rev­o­lu­tion’s KRAS drugs ap­pear com­pet­i­tive in sev­er­al lung can­cer set­tings

AI biotech In­sil­i­co Med­i­cine goes for third at­tempt at Hong Kong IPO

Sanofi scraps IGM deal; Lil­ly to pay $250M to con­tin­ue work with Pur­due Uni­ver­si­ty

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times